Adare’s scientific teams boast unprecedented experience in the development of oral solid dosage forms
Our formulation experts partner with you to provide innovative solutions to complex dosage form challenges.
- Dedicated GMP Development Laboratory
- Additional Non-GMP Small Scale Laboratory
-
- Provides additional early-stage non-GMP development capacity
- Produce smaller batches using less active pharmaceutical ingredients (APIs).
- Mirrors Adare’s pilot and production capabilities
- Start projects immediately
- Faster development timelines
- Integrated R&D validated through to commercial manufacturing
- Full-service capabilities for even the most complex product creation
- In-house regulatory affairs team with a proven global track record
- Flexible Business Model customized to fit your program
Speak With An Expert
Giuseppe Di Vincenzo
Chief Strategy Officer
Giuseppe leads our strategy, communications and internal pipeline development teams.
He was previously Vice President, Strategic and Commercial Development at Adare where he was responsible for commercial strategy, marketing, business development and internal pipeline development activities. Prior to that, he was Vice President Global Sales and Strategy at Aptalis Pharmaceutical Technologies. Before joining Aptalis, he held a number of senior positions at Eurand. He also held roles with Élan Corporation and Arthur D. Little.
Giuseppe holds a degree in Biology from the University Federico II of Naples, Italy and a Master of Business Administration from the London Business School, United Kingdom.
